Activest Wealth Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Activest Wealth Management’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-666	Closed	-$440	–	618
2024 Q2	$440	Buy	+666	New	+$415	﹤0.01%	464

Activest Wealth Management's VBIV Position: Q3 2024 in Review

Activest Wealth Management sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2024, closing a stake of 666 shares — an estimated $440 sold.

Activest Wealth Management first reported a position in VBIV in Q2 2024 and held it in 1 quarter. The position peaked at $440 in Q2 2024. 1 fund tracked by Wall St. Rank holds VBIV as of Q3 2024.

Activest Wealth Management reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2024 after selling out during the quarter.
Activest Wealth Management sold 666 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2024, an estimated $440.
Activest Wealth Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2024 and held it in 1 quarter.
Activest Wealth Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $440 in Q2 2024.
1 fund tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2024.

Based on Activest Wealth Management's 13F filing for Q3 2024, filed 12 Nov 2024.